| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TScan Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 420,000 | 20 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TCRX | TScan Therapeutics, Inc. | 20 Jan 2026 | 1 | $0 | 4 | Chief Medical Officer | 22 Jan 2026, 17:27 |
| TCRX | TScan Therapeutics, Inc. | 03 Jan 2025 | 1 | $0 | 4 | Chief Medical Officer | 11 Feb 2025, 17:47 |
| TCRX | TScan Therapeutics, Inc. | 01 May 2024 | 1 | $0 | 4 | Chief Medical Officer | 03 May 2024, 16:05 |
| TCRX | TScan Therapeutics, Inc. | 22 Apr 2024 | 0 | $0 | 3 | Chief Medical Officer | 02 May 2024, 16:05 |